CLINICAL_TRIALS
trial_result
· 2021-06-23
Clinical Trial Update: A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly [Phase 3]
Summary
Phase 3 trial completed evaluating RTB101 for preventing clinically symptomatic respiratory illness in the elderly; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Restorbio Inc. | Conditions: Respiratory Tract Infections | Phase 3 | Status: COMPLETED | Results posted: 2021-06-23